Amyaouch Bradaia
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents.
Journal: Neuron
Published: April 03, 2025
Skin inflammation and itch response are independently regulated by distinct nociceptor subsets.
Journal: Immunity
Published: November 04, 2024
Entourage effects of nonpsychotropic cannabinoids on visceral sensitivity in experimental colitis.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 23, 2024
Induction of antiviral interferon-stimulated genes by neuronal STING promotes the resolution of pain in mice.
Journal: The Journal of clinical investigation
Published: October 10, 2023
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
Journal: Experimental neurology
Published: December 03, 2015
Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 06, 2012
Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Journal: PloS one
Published: July 05, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
Journal: Molecular psychiatry
Published: May 30, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Journal: Biological psychiatry
Published: January 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026